Secondary hyperlipoproteinaemia type 3 (Q102536): Difference between revisions
From determinar.ia.br - Determine suas informações
Created a new Item |
Changed an Item |
||||||||||||||
| (6 intermediate revisions by the same user not shown) | |||||||||||||||
| description / pt-br | description / pt-br | ||||||||||||||
Forma secundária que envolve níveis anormalmente elevados de qualquer um ou todos os lipídios e/ou lipoproteínas séricos. Esta forma é devido a quilomícrons elevados e IDL (lipoproteína de densidade intermediária). Também conhecida como doença beta ampla ou disbetalipoproteinemia, a causa mais comum dessa forma é a presença do genótipo ApoE E2/E2. É devido ao colesterol rico em VLDL. | |||||||||||||||
| description / en | description / en | ||||||||||||||
This is the secondary form and involves abnormally elevated levels of any or all lipids and/or lipoproteins in the blood. This form is due to high chylomicrons and IDL (intermediate density lipoprotein). Also known as broad beta disease or dysbetalipoproteinaemia, the most common cause for this form is the presence of ApoE E2/E2 genotype. It is due to cholesterol-rich VLDL. | |||||||||||||||
| Property / Canonical URI | |||||||||||||||
| Property / Canonical URI: https://id.who.int/icd/entity/887392477 / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / CURIE | |||||||||||||||
CID11:ID_887392477 | |||||||||||||||
| Property / CURIE: CID11:ID_887392477 / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / Canary Token | |||||||||||||||
dki-india-ID_887392477 | |||||||||||||||
| Property / Canary Token: dki-india-ID_887392477 / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / Verification Status | |||||||||||||||
Concluído | |||||||||||||||
| Property / Verification Status: Concluído / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / Knowledge Architect | |||||||||||||||
| Property / Knowledge Architect: https://pauloleads.com.br/cases-publicos/ / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / Collection date | |||||||||||||||
15 August 2026
| |||||||||||||||
| Property / Collection date: 15 August 2026 / rank | |||||||||||||||
Normal rank | |||||||||||||||
Latest revision as of 19:35, 16 August 2026
This is the secondary form and involves abnormally elevated levels of any or all lipids and/or lipoproteins in the blood. This form is due to high chylomicrons and IDL (intermediate density lipoprotein). Also known as broad beta disease or dysbetalipoproteinaemia, the most common cause for this form is the presence of ApoE E2/E2 genotype. It is due to cholesterol-rich VLDL.
| Language | Label | Description | Also known as |
|---|---|---|---|
| default for all languages | ID_887392477 |
||
| English | Secondary hyperlipoproteinaemia type 3 |
This is the secondary form and involves abnormally elevated levels of any or all lipids and/or lipoproteins in the blood. This form is due to high chylomicrons and IDL (intermediate density lipoprotein). Also known as broad beta disease or dysbetalipoproteinaemia, the most common cause for this form is the presence of ApoE E2/E2 genotype. It is due to cholesterol-rich VLDL. |
Statements
CID11:ID_887392477
0 references
dki-india-ID_887392477
0 references
Concluído
0 references
15 August 2026
0 references
